Does AMINOLEVULINIC ACID Cause Off label use? 178 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Off label use have been filed in association with AMINOLEVULINIC ACID (AMELUZ). This represents 10.8% of all adverse event reports for AMINOLEVULINIC ACID.
178
Reports of Off label use with AMINOLEVULINIC ACID
10.8%
of all AMINOLEVULINIC ACID reports
1
Deaths
3
Hospitalizations
How Dangerous Is Off label use From AMINOLEVULINIC ACID?
Of the 178 reports, 1 (0.6%) resulted in death, 3 (1.7%) required hospitalization, and 2 (1.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMINOLEVULINIC ACID. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does AMINOLEVULINIC ACID Cause?
Drug ineffective (293)
Wrong technique in product usage process (173)
Erythema (144)
Product quality issue (132)
Poor quality product administered (124)
Pain (102)
Product dose omission issue (93)
Application site pain (90)
Application site erythema (81)
Accidental exposure to product (73)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AMINOLEVULINIC ACID Alternatives Have Lower Off label use Risk?
AMINOLEVULINIC ACID vs AMINOPHYLLINE
AMINOLEVULINIC ACID vs AMINOSALICYLATE
AMINOLEVULINIC ACID vs AMINOSALICYLIC ACID
AMINOLEVULINIC ACID vs AMIODARONE
AMINOLEVULINIC ACID vs AMISULPRIDE